TV's Scarpetta Suggests We Can 3D Print Full Human Organs — Reality Is Not Yet

Scarpetta Brings Bioprinting to Prime Video

Amazon Prime's new series Scarpetta, starring Nicole Kidman as forensic pathologist Kay Scarpetta, has sparked fresh conversation about 3D bioprinting of human organs. The show features a fictional biotech company capable of printing fully functional organs in microgravity — a concept that sounds revolutionary but remains firmly in the realm of science fiction.

What the Show Gets Right

The series correctly identifies microgravity as a promising environment for bioprinting. In zero gravity, scientists believe it's easier to build complex biological structures without them collapsing under their own weight. Real-world experiments aboard the International Space Station, conducted by companies like Redwire, have already demonstrated early-stage bioprinting in space.

The show draws a plausible connection between space-based research and the future of organ printing — but it pushes the timeline roughly a decade or more ahead of where the science actually stands.

Where Reality Falls Short

Nobody is printing a fully transplantable human heart, kidney, or liver yet. The closest real-world equivalents include:

• Wake Forest's kidney nephrons — developed in 2024, these can filter blood and produce functional urine in trials
• Heart tissue — researchers have created beating heart tissue that functions for weeks
• Liver patches — vascularized liver tissue has been printed and tested

These are remarkable advances, but they're a far cry from the full organs depicted in Scarpetta.

Clinical Timeline Projections

According to current projections:

• 2027 — Skin and bladder could reach clinical use (simplest organs)
• 2032 — Vascularized kidneys may become available
• 2038 — Full hearts could potentially be printed

The biggest challenge remains vascularization — creating the tiny blood vessel networks needed to keep thick tissues alive. Without blood supply, printed tissues die from the inside out.

The Road Ahead

While Scarpetta's vision of on-demand organ printing is compelling, the reality involves significant technical hurdles. Researchers are making progress with sacrificial ink techniques, stem cell technology, and automated bioprinting systems. But for now, the technology remains a powerful narrative tool rather than a medical reality.

For the 120,000+ patients on transplant waiting lists in the US alone, 3D printed organs can't come soon enough — but they'll need to wait a bit longer than what Scarpetta suggests.